Effectiveness of combination therapy with ISA101 vaccine for the treatment of human papillomavirus-induced cervical cancer

Effectiveness of combination therapy with ISA101 vaccine for the treatment of human papillomavirus-induced cervical cancer

Cervical cancer is one of the women-associated tumors that affects numerous people yearly. It is the fourth most common malignancy in women worldwide. Following early diagnosis, this cancer can be cured mainly by traditional methods such as surgery, tumor resection, and chemotherapy; nonetheless, it...

Full description

Bibliographic Details
Main Authors: Haigang Ding, Juan Zhang, Feng Zhang, Yan Xu, Yijun Yu, Wenqing Liang, Qingping Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
cervical cancer
vaccine
ISA101
immunotherapy
human papilloma virus
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.990877/full

Similar Items

Similar Items